Novel genetic risk factors for venous thrombosis; a haplotype- based candidate gene approach Uitte de Willige, S.

(1)

Novel genetic risk factors for venous thrombosis; a haplotype-

based candidate gene approach

Uitte de Willige, S.

Citation

Uitte de Willige, S. (2007, May 23). Novel genetic risk factors for venous

thrombosis; a haplotype-based candidate gene approach. Hemostasis and

Thrombosis Research Center, Department of Hematology, Faculty of Medicine,

Leiden University. Retrieved from https://hdl.handle.net/1887/11970

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis

in the Institutional Repository of the University of Leiden

Downloaded from: https://hdl.handle.net/1887/11970

(2)

Publications and Abstracts

(3)

(4)

Publications and Abstracts

165

Publications

Uitte de Willige S, Vos HL, de Visser MCH, Rosendaal FR, Bertina RM. Selectin haplotypes and the risk of deep venous thrombosis; influence of linkage disequilibrium with the Factor V Leiden mutation. Submitted for publication.

Uitte de Willige S, Pyle ME, Vos HL, de Visser MCH, Lally C, Dowling NF, Hooper WC, Bertina RM, Austin H. Polymorphisms in the 3’-end of the fibrinogen gamma gene and risk of venous thromboembolism in the African-American and Caucasian population Submitted for publication.

Uitte de Willige S, Rietveld IM, de Visser MCH, Vos HL, Bertina RM. Polymorphism 10034C>T is Located in a Functional Cleavage stimulation Factor (CstF) Binding Site of the Fibrinogen Gamma Gene and Influences the γ'/γA mRNA Ratio. Submitted for publication.

Cheung EYL, Uitte de Willige S, Vos HL, Leebeek FWG, Dippel DWJ, Bertina RM, de Maat MPM. Fibrinogen gamma in ischemic stroke: a case-control study. Submitted for publication.

El Galta R, Uitte de Willige S, de Visser MCH, Hsu L, Houwing-Duistermaat JJ.

Generalizing Terwilliger’s likelihood approach: a new score test for genetic association. Submitted for publication.

Mosesson MW, Hernandez I, Raife TJ, Medved L, Yakovlev S, Siebenlist KR, Simpson-Haidaris PJ, Uitte de Willige S, Bertina RM. Plasma fibrinogen gamma prime chain content in the thrombotic microangiopathy syndrome. Journal of Thrombosis and Haemostasis 2007;5:62-69.

Uitte de Willige S, Doggen CJM, de Visser MCH, Bertina RM, Rosendaal FR.

Haplotypes of the fibrinogen gamma gene do not affect the risk of myocardial infarction. Journal of Thrombosis and Haemostasis 2006;4(2):474-6.

Uitte de Willige S, de Visser MCH, Houwing-Duistermaat JJ, Rosendaal FR, Vos HL, Bertina RM. Genetic variation in the fibrinogen gamma gene increases the risk of deep venous thrombosis by reducing plasma fibrinogen γ’ levels. Blood 2005;106(13):4176-4183.

White SJ, Uitte de Willige S, Verbove D, Politano L, Ginjaar I, Breuning MH, den Dunnen JT. Sarcoglycanopathies and the risk of undetected deletion alleles in diagnosis. Human Mutation 2005;26(1):59-66.

(5)

Uitte de Willige S, van Marion V, Rosendaal FR, Vos HL, de Visser MCH, Bertina RM. Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis. Journal of Thrombosis and Haemostasis 2004;2(8):1305-1310.

Abstracts

Uitte de Willige S, Rietveld IM, de Visser MCH, Vos HL, and Bertina RM.

Polymorphism 10034C>T is Located in a Functional Cleavage stimulation Factor (CstF) Binding Site of the Fibrinogen Gamma Gene and Influences the γ'/γA mRNA Ratio. Blood 2006;108(11):543. (Oral presentation at the 48^th Annual Meeting and Exposition of the American Society of Hematology, Orlando, Florida, US).

Uitte de Willige S, Rietveld IM, de Visser MCH, Vos HL, and Bertina RM. The T allele of the fibrinogen gamma 10034C>T polymorphism is located in a functional CstF consensus and reduces the efficiency of alternative splicing of the fibrinogen gamma gene. (Oral presentation at the XIXth International Fibrinogen Workshop 2006, Guildford, UK).

Cheung EY, Uitte de Willige S, Vos HL, Leebeek FW, Dippel D, Bertina RM, de Maat MPM. Haplotypes of the fibrinogen gamma gene in ischaemic stroke: A case-control study. (Poster presentation at the XIXth International Fibrinogen Workshop 2006, Guildford, UK).

Uitte de Willige S, de Visser MCH, Houwing-Duistermaat JJ, Rosendaal FR, Vos HL and Bertina RM. Fibrinogen gamma haplotype 2 increases the risk of deep venous thrombosis by reducing plasma fibrinogen γ' levels. (Poster presentation at the XIXth International Fibrinogen Workshop 2006, Guildford, UK).

Cheung EY, Uitte de Willige S, Vos HL, Leebeek FW, Dippel D, Bertina RM, de Maat MPM. Haplotypes of the fibrinogen gamma gene in ischaemic stroke: A case-control study. Britisch Journal of Haemotology 133: 94 Suppl. (Poster presentation at the 46^th Annual Scientific Meeting of the British Society for Haematology).

Uitte de Willige S, de Visser MCH, Houwing-Duistermaat JJ, Rosendaal FR, Vos HL, Bertina RM. Haplotypes of the fibrinogen genes, plasma fibrinogen levels and the risk of deep venous thrombosis. Journal of Thrombosis and Haemostasis 2005; vol.

3 Suppl 1: 110. (Oral presentation at the XXTH Congress of the International Society of Thrombosis & Haemostasis, Sydney, Australia).

Uitte de Willige S, van Marion V, Rosendaal FR, Vos HL, de Visser MCH, Bertina

(6)

Publications and Abstracts

167 thrombosis. Pathophysiology of Haemostasis and Thrombosis 2004, vol. 33 Suppl 2:

OC097. (Oral presentation at the 18^th International Congress on Thrombosis organized by The Mediterranean League against Thromboembolic Diseases, Ljubljana, Slovenia).

Uitte de Willige S, van Marion V, Rosendaal FR, Vos HL, de Visser MCH and Bertina RM. Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis. (Oral presentation at the Annual Symposium 2004 of the Dutch Society of Thrombosis and Haemostasis, Houthalen, Belgium).

Den Dunnen JT, Kriek M, White S, Kalf M, Uitte de Willige S, Van Ommen GJB, Breuning MH. Screening for chromosomal aberrations in mentally retarded patients using MAPH. American journal of human Genetics 2002, 71(4): 499 1927 Suppl. S.

White SJ, Kalf ME, Uitte de Willige S, Ginjaar HB, van Ommen GJB, den Dunnen JT, breuning MH. Detection of exonic deletions/duplications in neuromuscular disorders using multiplex amplifiable probe hybridization. Neuromuscular Disorders 2002, vol 12(7-8):765-766.

de Kort G, Uitte de Willige S, Spaans A, Postma C, Franck P. Nieuwe methode voor mutatiescreening bij patienten met hereditaire sferocytose. Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde 2000, vol. 25, no. 2;

84-85.